Skip to content
Catholic Online Logo

By Catholic Online (NEWS CONSORTIUM)

4/6/2014 (2 years ago)

Catholic Online (www.catholic.org)

Drug cut in half the risk that cancer would worsen

An important treatment option in the fight against breast cancer may be waiting in the wings. Researchers say a new type of drug could help prevent advanced breast cancer from worsening. The potential is great for breast cancer patients, and makes for a potential blockbuster product for Pfizer.

While Pfizer remains in the lead to bring this new class of drugs to market, Novartis has begun late-stage testing of its own CDK 4/6 inhibitor.

While Pfizer remains in the lead to bring this new class of drugs to market, Novartis has begun late-stage testing of its own CDK 4/6 inhibitor.

Highlights

By Catholic Online (NEWS CONSORTIUM)

Catholic Online (www.catholic.org)

4/6/2014 (2 years ago)

Published in Health

Keywords: Pfizer, breast cancer, palbociclib


LOS ANGELES, CA (Catholic Online) - Said drug cut in half the risk that cancer would worsen, or progress, researchers said. The median time before the disease progressed or the women died was 20.2 months for those who received the drug, compared with 10.2 months for the control group.

"The magnitude of benefit we are seeing is not something commonly seen in cancer medicine studies," Dr. Richard S. Finn, a principal investigator in the study, says. Finn, an oncologist at the University of California, Los Angeles, called the results "quite groundbreaking."

No child need ever go to bed hungry -- Learn how you can help!


Known as palbociclib, the drug also appeared to prolong survival but not by a statistically significant amount. Those who received the drug lived a median of 37.5 months in contrast with 33.3 months for those in the control group.

The results from the Phase 2, or mid-stage, study were presented here at the annual meeting of the American Association for Cancer Research. Palbociclib is considered a jewel in Pfizer's product pipeline, with analysts predicting annual sales of billions of dollars. Amgen is entitled to an eight percent royalty on sales of the drug.

Some investors may have been letdown due to the drug, partly because they were not quite as good as interim results presented about halfway through the trial. At that point, the difference in median progression-free survival was 26.1 months for palbociclib versus 7.5 months for the control group.

Finn stresses that a statistically significant survival benefit should not have been expected at this point because only 61 of the 165 patients in the trial had died. Patients can use other drugs after leaving the trial, which can dilute any effect of palbociclib.

Palbociclib slows the proliferation of cancer cells by inhibiting the activity of two related enzymes involved in cell division; cyclin-dependent kinases 4 and 6.

While Pfizer remains in the lead to bring this new class of drugs to market, Novartis has begun late-stage testing of its own CDK 4/6 inhibitor. While breast cancer is the initial focus, the drugs are being tested for other cancers.

Breast cancer specialists not involved in the study were encouraged -- but expressed caution. "These results are strikingly positive and with a large potential impact to patients," Dr. José Baselga said in a speech at the conference discussing the results.

Baselga, the physician in chief at the Memorial Sloan-Kettering Cancer Center, also said the results might have been biased because the study investigators, who determined whether tumors had progressed, knew which patients were getting palbociclib.

Dr. Eric P. Winer, chief of women's cancers at the Dana-Farber Cancer Institute in Boston, says larger studies were still needed.

"This is a small Phase 2 trial - not tiny, but not the kind of study that would typically lead to a change in practice," he said.

---


Pope Francis: end world hunger through 'Prayer and Action'


Copyright 2016 - Distributed by THE CALIFORNIA NETWORK

Pope Francis Prayer Intentions for SEPTEMBER 2016
Universal:
Centrality of the Human Person: That each may contribute to the common good and to the building of a society that places the human person at the center.
Evangelization: Mission to Evangelize: That by participating in the Sacraments and meditating on Scripture, Christians may become more aware of their mission to evangelize.



Comments


More Health

God is good! Man learns to walk after FOUR DECADES in wheelchair Watch

Image of Rufino Borrego (not pictured) no longer requires his wheelchair.

By Kenya Sinclair (CALIFORNIA NETWORK)

Rufino Borrego was only 13-years-old when he was diagnosed with muscular dystrophy, leading to 43-years of his life spent confined to a wheelchair. LOS ANGELES, CA (Catholic Online) - Borrego was diagnosed by doctors at a Lisbon hospital and he spent the majority of ... continue reading


5 things you NEED to know about drug-resistant superbugs and antimicrobial resistance Watch

Image of Do YOU know how to protect yourself?

By Kenya Sinclair (CALIFORNIA NETWORK)

The United Nations General Assembly voted to take "a broad coordinated approach" to antimicrobial resistance, which is growing at such an alarming rate, millions are expected to die by 2050. LOS ANGELES, CA (Catholic Online) - "This is only the fourth time a health ... continue reading


St. Padre Pio helps dying newborn miraculously recover after 25 DAYS on life support Watch

Image of (Photo by: Ciara Wilkinson/Irish Mirror)

By Abigail James (CALIFORNIA NETWORK)

Three-month-old Caitlin Dooley suffered from a life-threatening heart condition since the day she was born. Just when the Dooley family began to lose hope, St. Padre Pio stepped in. LOS ANGELES, CA (Catholic Online) - According to the Irish Mirror, at just 11-days-old, ... continue reading


Pray for the children with brain cancer - the number 1 cancer responsible for childhood deaths Watch

Image of The number one cancer killing children in the US is of the brain.

By Kenya Sinclair (CALIFORNIA NETWORK)

A new federal report revealed brain cancer is now the leading cancer killer of children in the United States. LOS ANGELES, CA (Catholic Online) - Sally Curtin and her colleagues at the NCHS, part of the CDC, discovered brain tumors and leukemia are the two  most ... continue reading


Harvard scientists reveal surprising footage dubbed 'Hollywood wizardry' Watch

Image of Harvard scientists release a timelapse video featuring the evolution of antibiotic resistance.

By Kenya Sinclair (CALIFORNIA NETWORK)

Harvard scientists have finally released video evidence of the astounding strength of nature. LOS ANGELES, CA (Catholic Online) - Scientists have long attempted to find a cure for bacteria-related illness such as the common cold but in a new video recently released by ... continue reading


'The killing of an innocent human being is always wrong'- Doctors suggest killing coma patients to harvest organs Watch

Image of Is it right to kill coma patients for their organs?

By Kevin J. Jones (CNA/EWTN News)

There are severe ethical shortcomings in a British doctor's proposal to help unconscious patients die so their organs can be used for transplants, one critic has said. London, England (CNA/EWTN News) - "The killing of an innocent human being is always wrong - even when ... continue reading


Don't blame the free market for drug prices out of control -- blame corruption Watch

Image of Prescription drug prices are higher in the USA than anywhere in the world.

By Marshall Connolly (CALIFORNIA NETWORK)

It's no secret that prescription drug prices in the U.S. are out of control. Americans pay far more for their drugs than people in any other industrialized nation. This excess needs correction before it collapses the American healthcare system. LOS ANGELES, CA ... continue reading


'Loneliness has to be everybody's business' - How being alone can affect your mental and physical health Watch

Image of You don't have to be alone.

By Kenya Sinclair (CALIFORNIA NETWORK)

In this age of connection, researchers have discovered a surprising rise in people suffering debilitating loneliness - but there is hope. LOS ANGELES, CA (Catholic Online) - Fortune describes chronic loneliness as a "modern-day epidemic."John Cacioppo, the director of ... continue reading


Scientists resurrect an ancient killer plague, but why? Watch

Image of The Plague of Justinian killed almost 15 percent of the world's population in the sixth century AD.

By Marshall Connolly (CALIFORNIA NETWORK)

Scientists have reconstructed the genome of an ancient bacteria that was responsible for one of the most devastating plagues in human history. The Plague of Justinian has been resurrected, at least in the lab. LOS ANGELES, CA (California Network) - The Plague of ... continue reading


New study reveals the truth about sexual orientation and gender identity Watch

Image of The truth about sexual orientation and gender identity (McPIG: An Introduction to the McGill University Sexual Identity Centre).

By (CNA/EWTN News)

For most young people who experience feelings of gender dysphoria, the experience is in fact temporary, and a non-heterosexual orientation is not as fixed as sometimes claimed, a new overview of the relevant research says. Washington D.C. (CNA/EWTN News) - "Only a ... continue reading


All Health News

Newsletters

Newsletter Sign Up icon

Stay up to date with the latest news, information, and special offers

Subscribe to Catholic OnlineYouTube Channel

Daily Readings

Reading 1, Daniel 7:9-10, 13-14
9 While I was watching, thrones were set in place and one most venerable ... Read More

Psalm, Psalms 138:1-2, 2-3, 4-5
1 [Of David] I thank you, Yahweh, with all my heart, for you have ... Read More

Gospel, John 1:47-51
47 When Jesus saw Nathanael coming he said of him, 'There, truly, is an ... Read More

Saint of the Day

Saint of the Day for September 29th, 2016 Image

St. Michael the Archangel
September 29: Saint Michael the Archangel isn't a saint, but ... Read More